LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

LLY

724.86

-2.66%↓

NVO

122.65

-0.04%↓

MRK

125.78

+0.49%↑

ABBV

166.3

+0.95%↑

TMO

544.88

+0.67%↑

HomeStock ListBio-Techne Corp

Bio-Techne Corp

Closed

62.17 -0.97

Overview

Share price change

24h

Current

Min

61.01

Max

62.78

Key metrics

By Trading Economics

Income

-24M

27M

Sales

-4.3M

273M

P/E

Sector Avg

50.636

23.904

EPS

0.4

Dividend yield

0.392

Profit margin

10.075

Employees

3,050

EBITDA

-38M

84M

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+25.76 upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

0.39%

7.76%

Next Earnings

1 May 2024

Next Dividend date

24 May 2024

Next Ex Dividend date

10 May 2024

Market Stats

By TradingEconomics

Market Cap

-679M

10B

Previous open

63.14

Previous close

62.17

Technical Score

By Trading Central

Confidence

Bearish Evidence

Bio-Techne Corp Chart

Related News

17 Apr 2024, 20:33 UTC

Earnings

CSX 1Q Revenue Drops on Lower Fuel Surcharge While Volumes Rise

17 Apr 2024, 23:13 UTC

Top News

Fed's Mester Says Recent Inflation Means Longer Wait for Rate Cuts -- Barrons.com

17 Apr 2024, 22:33 UTC

Market Talk
Earnings
Acquisitions, Mergers, Takeovers

Alcoa Trying to Sell Aluminum Smelter in Spain -- Market Talk

17 Apr 2024, 21:32 UTC

Top News

Tesla Shareholders to Vote on Musk Pay, Texas Incorporation -- 6th Update

17 Apr 2024, 21:31 UTC

Market Talk
Earnings

Kinder Morgan: Relying Only on Renewables For Energy Needs 'Fatally Flawed' -- Market Talk

17 Apr 2024, 21:02 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

17 Apr 2024, 21:02 UTC

Market Talk

Mexican Stocks Close Lower; Peso Strengthens Against Dollar -- Market Talk

17 Apr 2024, 20:51 UTC

Top News

Tesla Shareholders to Vote on Musk Pay, Texas Incorporation -- 6th Update

17 Apr 2024, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

17 Apr 2024, 20:40 UTC

Market Talk
Earnings

Kinder Morgan Sees Energy Hogs AI, Crypto Mining Boosting Natural Gas Demand -- Market Talk

17 Apr 2024, 20:26 UTC

Top News

S&P 500 Falls for Fourth Straight Session on Fading Hopes for Interest-Rate Cuts -- WSJ

17 Apr 2024, 20:20 UTC

Earnings

Chip Gear Giant ASML Misses Q1 Sales Goal, Offers Soft Outlook -- IBD

17 Apr 2024, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

17 Apr 2024, 20:07 UTC

Earnings

Kinder Morgan: Adjusting Long-Term Leverage Target From Around 4.5 Times Net Debt-to-Adjusted EBITDA to a Range of 3.5 to 4.5 Times >KMI

17 Apr 2024, 20:07 UTC

Earnings

Kinder Morgan Sees 2024 EPS $1.22 >KMI

17 Apr 2024, 20:05 UTC

Earnings

Kinder Morgan 1Q Rev $3.84B >KMI

17 Apr 2024, 20:05 UTC

Earnings

Kinder Morgan 1Q Net $746M >KMI

17 Apr 2024, 20:05 UTC

Earnings

Kinder Morgan 1Q EPS 33c >KMI

17 Apr 2024, 20:04 UTC

Earnings

CSX Corp: Looking Ahead, With Favorable Trends Across Many of the Markets We Serve, We Are Eager to Build on Our Momentum Over the Rest of the Yr and Beyond >CSX

17 Apr 2024, 20:04 UTC

Earnings

CSX Corp: 1Q Revenue Totaled $3.68B, Declining 1% Yr-Over-Yr as Lower Fuel Surcharge, Decline in Other Rev, Weaker Trucking Rev, Reduced Export Coal Prices Offset Gains in Merchandise Pricing and Higher Intermodal and Coal Volumes, Rev Was Flat Sequentially >CSX

17 Apr 2024, 20:04 UTC

Earnings

CSX Corp: Total Volume of 1.53M Units for 1Q Was 3% Higher Compared to 1Q 2023, With Intermodal Volume Up 7%, Coal Volume Up 2%, and Merchandise Volume Flat >CSX

17 Apr 2024, 20:01 UTC

Market Talk

Canada Dollar Rebounds Slightly After Week-Long Weakness -- Market Talk

17 Apr 2024, 20:01 UTC

Earnings

CSX Corp 1Q Rev $3.68B >CSX

17 Apr 2024, 20:01 UTC

Earnings

CSX Corp 1Q Net $893M >CSX

17 Apr 2024, 20:01 UTC

Earnings

CSX Corp 1Q EPS 46c >CSX

17 Apr 2024, 19:42 UTC

Market Talk

Declining Chinese Export Purchases Sink Livestock -- Market Talk

17 Apr 2024, 19:31 UTC

Hot Stocks

Stocks to Watch Wednesday: United Airlines, ASML, Alcoa, Trump Media -- WSJ

17 Apr 2024, 19:26 UTC

Market Talk

Former Canada Central Banker Says Worst Fears Realized About Budget -- Market Talk

17 Apr 2024, 19:15 UTC

Earnings

Prologis Warns of Slowing Industrial Real-Estate Market -- 2nd Update

17 Apr 2024, 19:11 UTC

Market Talk

Oil Futures Post Third Straight Loss on U.S. Stock Build -- Market Talk

Peer Comparison

Price change

Bio-Techne Corp forecast

Price Target

By TipRanks

25.76% upside

12 Months Forecast

Average 80.5 USD  25.76%

High 95 USD

Low 65 USD

Based on 9 Wall Street analysts offering 12 month price targets forBio-Techne Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

9 ratings

7

Buy

2

Hold

0

Sell

Technical Score

By Trading Central

N/A / 68.88Support & Resistance

Short Term

Bearish Evidence

Intermediate Term

Strong Bearish Evidence

Long Term

Strong Bearish Evidence

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Bio-Techne Corp

Bio-Techne Corporation is a developer, manufacturer, and seller of life science reagents, instruments and services for the research, diagnostics, and bioprocessing markets. The Company operates through two segments: Protein Sciences and Diagnostics and Genomics. The Protein Sciences segment is a developer and manufacturer of biological reagents used in all aspects of life science research, diagnostics and cell and gene therapy. This segment also includes proteomic analytical tools, both manual and automated, that offer researchers and pharmaceutical manufacturers efficient options for automated western blot and multiplexed ELISA workflow. The Diagnostics and Genomics segment develops and manufactures diagnostic products, including controls, calibrators, and diagnostic assays for the regulated diagnostics market, exosome-based molecular diagnostic assays, advanced tissue-based in-situ hybridization assays for spatial genomic and tissue biopsy analysis, and genetic and oncology kits.